<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJST</journal-id><journal-title-group><journal-title>Open Journal of Stomatology</journal-title></journal-title-group><issn pub-type="epub">2160-8709</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojst.2023.139025</article-id><article-id pub-id-type="publisher-id">OJST-127948</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Histopathological and Immunohistochemical Study of Peri-Implant Epithelium
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yoshikazu</surname><given-names>Nakayama</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chieko</surname><given-names>Taguchi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mitsuko</surname><given-names>Nakayama</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Masaaki</surname><given-names>Suemitsu</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kayo</surname><given-names>Kuyama</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Pathology, Nihon University School of Dentistry at Matsudo, Chiba, Japan</addr-line></aff><aff id="aff2"><addr-line>Department of Community Oral Health, Nihon University School of Dentistry at Matsudo, Chiba, Japan</addr-line></aff><aff id="aff1"><addr-line>Department of Oral Pathology, Nihon University Graduate School Dentistry at Matsudo, Chiba, Japan</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>09</month><year>2023</year></pub-date><volume>13</volume><issue>09</issue><fpage>309</fpage><lpage>321</lpage><history><date date-type="received"><day>18,</day>	<month>August</month>	<year>2023</year></date><date date-type="rev-recd"><day>23,</day>	<month>September</month>	<year>2023</year>	</date><date date-type="accepted"><day>26,</day>	<month>September</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Human beta-defensins (HBDs), epithelial-derived antimicrobial peptides, contribute to gingival health and periodontal disease. Particularly, the upregulation of HBD-3 expression in periodontal tissues is described to contribute to periodontal tissue regeneration. Specifically, the upregulation of HBD-3 expression in periodontal tissues is described to contribute to periodontal tissue regeneration. But there has been insufficient investigation of the inner epithelium in peri-implantitis, especially the HBD expression patterns as protection against oral infection. 
  Objectives: The purpose of this study was to investigate the histopathological characteristics of the inner implant epithelium in peri-implantitis using histopathological and immunohistochemical methods and to compare it with the inner marginal epithelium in periodontitis. Materials and 
  Methods: The biopsied cases consisted of 10 peri-implantitis, 11 periodontitis, and 10 controls. HE observation, measurement of the thickness of the inner epithelium, and immunohistochemical analysis for Ki-67 and HBD-3 were conducted. 
  Results: Concerning the thickness of the inner epithelium, it was significantly higher in periodontitis (156.2 [138.0, 186.4] μm) than in peri-implantitis and control, 70.7 [67.5, 97.5] μm and 80.7 [76.6, 89.4] μm, respectively (p &lt; 0.001). The Ki-67 positivity rates, both for inner epithelium and outer epithelium, were significantly higher in the following order: periodontitis, peri-implantitis, and control (p &lt; 0.001). The inner epithelium is significantly elevated in the case of periodontitis (p &lt; 0.001). For HBD-3, the intensity and region score (IRS) was significantly higher for inner epithelium than for outer epithelium (superficial layer) (p &lt; 0.001) in all cases. The comparisons of IRS, significantly higher values were seen in inner epithelium of periodontitis than that of peri-implantitis (p &lt; 0.001). 
  Conclusion: Decreased production of HBD-3 in keratinocytes composing the inner implant epithelium may be one of the factors affecting tissue repair in peri-implantitis.
 
</p></abstract><kwd-group><kwd>Peri-Implantitis</kwd><kwd> Periodontitis</kwd><kwd> Ki-67</kwd><kwd> HBD-3</kwd><kwd> Inner Epithelium</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>After implant placement, an implant-epithelial interface is formed over the course of wound healing. However, since the covering epithelium that protects the inside communicates with the external environment, there is always a risk of inflammation. Peri-implant disease affects the tissues around implants and has an inflammatory origin. Despite the success rates of dental implants, peri-implant disease, which consists of two main conditions, peri-implant mucositis and peri-implantitis, is the most common complication in implant dentistry [<xref ref-type="bibr" rid="scirp.127948-ref1">1</xref>] . Peri-implant disease has a high-prevalence; the mean prevalences of peri-implant mucositis and peri-implantitis were 52% and 18%, respectively [<xref ref-type="bibr" rid="scirp.127948-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref2">2</xref>] .</p><p>The oral mucosa around a dental implant is covered by peri-implant epithelium (inner implant epithelium facing the implant and outer implant epithelium facing the oral cavity) [<xref ref-type="bibr" rid="scirp.127948-ref3">3</xref>] , and several studies of their characteristics when healthy have been reported [<xref ref-type="bibr" rid="scirp.127948-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref6">6</xref>] , but studies of the inner implant epithelium in peri-implantitis are very few [<xref ref-type="bibr" rid="scirp.127948-ref7">7</xref>] , and there has been insufficient investigation of the relationship with the mechanism of inflammation.</p><p>Oral epithelium consists of three protective barriers: a mechanical barrier, innate immunity, and adaptive immunity [<xref ref-type="bibr" rid="scirp.127948-ref8">8</xref>] . Defensins, a family of antimicrobial peptides, are vital contributors to the innate immune response due to their ability to recognize and neutralize invading microorganisms [<xref ref-type="bibr" rid="scirp.127948-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref9">9</xref>] . In particular, human beta-defensins (HBDs) are epithelial-derived antimicrobial peptides. The expression of three HBDs (HBD-1, 2, and 3) has been reported in oral mucosa and gingiva [<xref ref-type="bibr" rid="scirp.127948-ref10">10</xref>] , and they contribute to gingival health and periodontal disease [<xref ref-type="bibr" rid="scirp.127948-ref11">11</xref>] . Furthermore, it has been reported that increased HBD‑3 expression in periodontal tissue may contribute to periodontal regeneration [<xref ref-type="bibr" rid="scirp.127948-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref12">12</xref>] . However, the HBD expression patterns of inner implant epithelium as protection against oral infections, especially peri-implant disease, are not well understood [<xref ref-type="bibr" rid="scirp.127948-ref11">11</xref>] .</p><p>To investigate the histopathological features of the inner implant epithelium in peri-implantitis, the inner marginal epithelium of periodontitis and the inner implant epithelium were compared using histological and immunohistochemical methods.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Subjects</title><p>The characteristics of the subjects in this study are summarized in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Clinical and histopathological information for the study subjects</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Case</th><th align="center" valign="middle" >No.</th><th align="center" valign="middle" >Position</th><th align="center" valign="middle" >Age</th><th align="center" valign="middle" >Sex</th><th align="center" valign="middle" >Clinical diagnosis</th><th align="center" valign="middle" >Histopathological diagnosis</th></tr></thead><tr><td align="center" valign="middle" >Periodontitis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >33, 34, 35</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >periodontitis</td><td align="center" valign="middle" >Choronic periodontitis</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >46, 47</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >periodontitis</td><td align="center" valign="middle" >Choronic periodontitis</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >gingival lesion</td><td align="center" valign="middle" >Inflammatory granulation tissue</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >periodontitis</td><td align="center" valign="middle" >Choronic periodontitis</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >36, 37</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >mandibular cyst</td><td align="center" valign="middle" >Choronic periodontitis</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >mandibular cyst</td><td align="center" valign="middle" >Choronic periodontitis</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >periodontitis</td><td align="center" valign="middle" >Consistent with chronic marginal periodontitis</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >gingival carcinoma</td><td align="center" valign="middle" >Chronic marginal periodontitis</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >31, 32, 33</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >periodontitis</td><td align="center" valign="middle" >Choronic periodontitis</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >25, 26, 27</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >periodontitis</td><td align="center" valign="middle" >Inflammatory granulation tissue</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >23-27</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >periodontitis</td><td align="center" valign="middle" >Inflammatory granulation tissue</td></tr><tr><td align="center" valign="middle" >Peri-implantitis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >82</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >peri-implantitis</td><td align="center" valign="middle" >Inflammatory granulation tissue</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >36, 37</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >peri-implantitis</td><td align="center" valign="middle" >peri-implantitis</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >peri-implantitis</td><td align="center" valign="middle" >Inflammatory granulation tissue</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >34, 35</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >peri-implantitis</td><td align="center" valign="middle" >Inflammatory granulation tissue</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >63</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >peri-implantitis</td><td align="center" valign="middle" >Inflammatory granulation tissue</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >peri-implantitis</td><td align="center" valign="middle" >Inflammatory granulation tissue</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >35, 36, 37</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >peri-implantitis</td><td align="center" valign="middle" >Choronic peri-implantitis</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4647</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >peri-implantitis</td><td align="center" valign="middle" >Inflammatory granulation tissue,compatible with peri-impalntitis</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >peri-implantitis</td><td align="center" valign="middle" >Inflammatory granulation tissue</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >peri-implantitis</td><td align="center" valign="middle" >Inflammatory granulation tissue</td></tr></tbody></table></table-wrap><p>There were 10 cases of peri-implantitis (3 male, 7 female, 69.5 &#177; 8.6 years), 11 cases of periodontitis (7 male, 4 female, 67.4 &#177; 12.40 years), and 10 controls (5 male, 5 female, 52.3 &#177; 14.6 years). Patients with periodontitis, peri-implantitis, and epulis as a control were selected from the pathology files of the Department of Pathology, Nihon University School of Dentistry at Matsudo. The diagnostic criteria for peri-implant disease were based on the sixth European Workshop on Periodontology (EWP) [<xref ref-type="bibr" rid="scirp.127948-ref13">13</xref>] , the American Academy of Periodontology, and the eighth EWP [<xref ref-type="bibr" rid="scirp.127948-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref15">15</xref>] . Only cases in which the peri-implant (inner and outer) epithelium was collected histologically for use in histopathological and immunohistochemical investigations were included. The inner marginal epithelium attached to the epulis resection specimens of 10 cases was used as the control.</p><p>Included in this study were cases clinically diagnosed and biopsied by certified physicians or specialists of the Japanese Society of Oral and Maxillofacial Surgeons or Japanese Society of Oral Implantology. Excluded were patients with other specific inflammatory diseases including autoimmune diseases, oral mucosal diseases, malignant tumors, and those currently taking various preparations or medicines those may induce periodontal diseases.</p></sec><sec id="s2_2"><title>2.2. Histopathological and Immunohistochemical Examination</title><p>One set of sections was stained with hematoxylin and eosin (HE) using standard staining protocols. After HE observation, the thickness of the inner implant/marginal epithelium in each case was observed and photographed under high-power (&#215;200) observation with an optical microscope (BX51, Olympus, Japan) and randomly measured using Win Roof version 3.4 image analysis software (Image J, NIH, Bethesda, MD, USA) in 5 fields.</p><p>Immunohistochemical studies were conducted using 10% neutral formalin solution-fixed, paraffin-embedded tissues from all cases. Several serial 4-&#181;m-thick sections were prepared and deparaffinized in xylene and hydrated in graded ethanol solution. Ki-67 antigen (MIB-1, 1:100, Dako, Glostrup, Denmark) and HBD-3 antigen (1:200, Novus Biologicals, Littleton, CO, USA) were used to evaluate cell proliferative ability and biological defense mechanisms of the epithelium, respectively. After antigen retrieval (Ki-67, 10 mM Tris-EDTA buffer, pH 9.0, 40 min; HBD-3, 10 mM citrate buffer, pH 6.0, 20 min) and blocking (3% H<sub>2</sub>O<sub>2</sub>, 10 min), the slides were incubated with Ki-67 for 60 min and HBD-3 overnight at 4˚C. After the EnVision + Polymer System (Dako EnVision+ Dual Link System-HRP, Dako) was used for 60 min, it was developed in a solution of 3,3'-dianibobenzidine tetrahydrochloride (Dako Liquid DAB+ Substrate Chromogen System, Dako). Finally, all sections were counterstained with Mayer’s hematoxylin for 3 min. The procedures were conducted while confirming the absence of technical false positives and false negatives.</p><p>Ki-67 and HBD-3 induced dark brown reactions in epithelial cell nuclei and cytoplasm, respectively. For semi-quantitative evaluation, Ki-67 was evaluated by the positivity rate (number of positive cells/total number of cells). For HBD-3, staining intensity was graded as 0 (negative), 1 (weak), 2 (moderate), and 3 (strong); the stained region was scored as 0 (negative), 1 (&lt;10%), 2 (11% - 50%), 3 (51% - 80%), and 4 (&gt;80%). The two scores were multiplied, and the intensity and region score (IRS, value from 0 - 12) was determined [<xref ref-type="bibr" rid="scirp.127948-ref16">16</xref>] . The measurements were performed in 10 hot-spot areas by two oral pathologists and a dentist, and the means of these 10 measurements were recorded.</p></sec><sec id="s2_3"><title>2.3. Statistical Analysis</title><p>The SPSS 27.0 software package (IBM Inc., Armonk, NY, USA) was used to perform statistical analysis. To compare the lengths of epithelial legs, the Mann-Whitney U test was used. In the comparisons of average Ki-67 positivity rates for within the group of epithelial cell types were Wilcoxon signed-rank test, and inter-group of that were Kruskal-Wallis test and Steel-Dwass test used, respectively. As for HBD-3 for staining attitude, comparisons within the group of epithelial cell types were Friedman test and Bonferroni correction, and inter-group of that were the Kruskal-Wallis test and Steel-Dwass test used. A significance level of p &lt; 0.05 was considered significant.</p></sec><sec id="s2_4"><title>2.4. Compliance with Ethical Standards</title><p>Informed consent was obtained from all individuals included in the study. All procedures in studies involving human participants were conducted in accordance with the ethical standards of the Committee on Studies Involving Human Beings of Nihon University School of Dentistry at Matsudo (EC21-008A) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Histopathological Findings</title><p>1) Histopathological findings of the inner (marginal/implant) epithelium</p><p>Representative HE-stained features of the inner epithelium are shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. In periodontitis, the epithelial ridges extended irregularly, and a high degree of inflammatory cell infiltration was observed in the subepithelial connective tissue (<xref ref-type="fig" rid="fig1">Figure 1</xref>(a), <xref ref-type="fig" rid="fig1">Figure 1</xref>(b)). In peri-implantitis, although the inner implant epithelium was thin, it was slightly extended in some parts, and moderate infiltration of inflammatory cells was observed in the subepithelial connective tissue (<xref ref-type="fig" rid="fig1">Figure 1</xref>(c)). The superficial layer of the inner implant epithelium showed parakeratosis, and detachment of the keratin fragments was observed (<xref ref-type="fig" rid="fig1">Figure 1</xref>(d)). In the control, the inner marginal epithelium was non-keratinized stratified squamous epithelium that extended slightly in a bud shape (<xref ref-type="fig" rid="fig1">Figure 1</xref>(e)). The basal cells were columnar-shaped and arranged with a slight palisading pattern (<xref ref-type="fig" rid="fig1">Figure 1</xref>(f)).</p><p>2) Measurement results of inner (marginal/implant) epithelium thickness</p><p>It was significantly higher in periodontitis (156.2 [138.0, 186.4] &#181;m) than in peri-implantitis and control, 70.7 [67.5, 97.5] &#181;m and 80.7 [76.6, 89.4] &#181;m, respectively (p &lt; 0.001).</p></sec><sec id="s3_2"><title>3.2. Immunohistochemical Evaluation</title><p>Representative features on immunohistochemical staining with Ki-67 and HBD-3 in the inner/outer marginal epithelium of periodontitis and control, and inner/outer implant epithelium of peri-implantitis are shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p><p>1) Ki-67 staining findings</p><p>With Ki-67 staining, numerous positive reactions were detected throughout all layers of the inner marginal epithelium, whereas positive reactions were observed in the basal or para-basal layer of the outer marginal epithelium in periodontitis (<xref ref-type="fig" rid="fig2">Figure 2</xref>(a), <xref ref-type="fig" rid="fig2">Figure 2</xref>(b)). In peri-implantitis, positive reactions were detected in the basal or para-basal layer of the inner implant epithelium, whereas scattered positive reactions were observed in the basal layer of the outer implant epithelium (<xref ref-type="fig" rid="fig2">Figure 2</xref>(c), <xref ref-type="fig" rid="fig2">Figure 2</xref>(d)). In control, positive reactions were</p><p>scarcely observed in the inner marginal epithelium, but scattered positive reactions were observed in the basal layer of the outer marginal epithelium (<xref ref-type="fig" rid="fig2">Figure 2</xref>(e), <xref ref-type="fig" rid="fig2">Figure 2</xref>(f)).</p><p>2) HBD-3 staining findings</p><p>With HBD-3, the basal layer of the inner marginal epithelium showed a high degree of strong positivity, whereas in the outer marginal epithelium, positive reactions were detected from the basal and para-basal layers to the lower layers of the spinous layer in periodontitis (<xref ref-type="fig" rid="fig2">Figure 2</xref>(g), <xref ref-type="fig" rid="fig2">Figure 2</xref>(h)). In peri-implantitis, there was diffuse weakly positive staining throughout all layers in the inner implant epithelium, with weak staining in the parabasal layer of the</p><p>outer implant epithelium (<xref ref-type="fig" rid="fig2">Figure 2</xref>(i), <xref ref-type="fig" rid="fig2">Figure 2</xref>(j)). In control, the basal layer of the inner marginal epithelium showed moderate to weak reactions, whereas in the outer marginal epithelium, moderate to strong reactions were detected from the basal and para-basal layers to the entire spinous layer (<xref ref-type="fig" rid="fig2">Figure 2</xref>(k), <xref ref-type="fig" rid="fig2">Figure 2</xref>(l)).</p><p>3) Semi-quantitative evaluation of immunohistochemical staining</p><p>The Ki-67 positivity rates, both for inner epithelium and outer epithelium, were significantly higher in the following order: periodontitis, peri-implantitis, and control (p &lt; 0.001, <xref ref-type="table" rid="table2">Table 2</xref>). In addition, the rate was significantly higher in the outer epithelium than in the inner epithelium in peri-implantitis and control, however, the inner epithelium is significantly elevated in the case of periodontitis (p &lt; 0.001, <xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p><xref ref-type="table" rid="table3">Table 3</xref> shows the immunohistochemical attitude of HBD-3. For HBD-3, when comparing the epithelial types within the same disease, significant differences were observed among the three groups (inner epithelium, outer epithelium deep layer, and outer epithelium superficial layer) except for the staining region and IRS of the outer epithelium deep layer (p &lt; 0.001). In particular, the IRS was significantly higher for inner epithelium than for outer epithelium (superficial layer) (p &lt; 0.001) in the three groups. The comparisons of IRS for each epithelial type among the three groups, significantly higher values were seen in inner epithelium of periodontitis than that of peri-implantitis (p &lt; 0.001, <xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>The inner epithelium facing the enamel or implant consists histologically of</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Ki-67 positivity rate of each epithelium of periodontitis, peri-implantitis, and control</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="2"  >Inner epithelium</th><th align="center" valign="middle"  colspan="3"  >Outer epithelium</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >IQR</td><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >IQR</td><td align="center" valign="middle" >p<sup>a</sup></td></tr><tr><td align="center" valign="middle" >Periodontitis</td><td align="center" valign="middle" >29.65</td><td align="center" valign="middle" >26.76-31.60</td><td align="center" valign="middle" >19.37</td><td align="center" valign="middle" >18.42-22.61</td><td align="center" valign="middle" >0.003</td></tr><tr><td align="center" valign="middle" >Peri-implantitis</td><td align="center" valign="middle" >6.15</td><td align="center" valign="middle" >5.65-6.57</td><td align="center" valign="middle" >9.07</td><td align="center" valign="middle" >8.40-9.75</td><td align="center" valign="middle" >0.013</td></tr><tr><td align="center" valign="middle" >Control</td><td align="center" valign="middle" >0.96</td><td align="center" valign="middle" >0.54-1.42</td><td align="center" valign="middle" >2.87</td><td align="center" valign="middle" >2.63-2.95</td><td align="center" valign="middle" >0.005</td></tr></tbody></table></table-wrap><p>a; Wilcoxon rank sum test.</p><p><xref ref-type="table" rid="table3">Table 3</xref>. Immunohistochemical attitude of HBD-3.</p><disp-formula id="scirp.127948-formula24"><graphic  xlink:href="//html.scirp.org/file/4-1461103x4.png?20230928111415698"  xlink:type="simple"/></disp-formula><p>HBD-3; human β defensin-3. IRS: Immunohistochemical intensity and region socre, superficial layer; consisted of para-basal to spinpous layer. a; inner epithelium vs outer epithelium deep layer vsouter epithelium superficial layer, Friedman test; b; inner epithelium vs outer epithelium deep layer, Bonferroni correction; c; inner epithelium vs outer epithelium superficial lyer, Bonferroni correction; d; outer epithelium deep lyer vs outer epithelium superficial layer, Bonferroni correction; *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001. n.s.; not significant; IQR: Interquartile Range.</p><p>sulcular epithelium (SE) and junctional epithelium (JE) [<xref ref-type="bibr" rid="scirp.127948-ref17">17</xref>] . In humans, the inner epithelium is clearly observed when there is a pathological periodontal pocket [<xref ref-type="bibr" rid="scirp.127948-ref7">7</xref>] . In this study, due to the difficulty distinguishing between SE and JE based on inflammatory modifications, both were collectively observed and compared as the “inner epithelium”, and with periodontitis they were thicker. Turnover of the inner epithelium is activated during the process of repair of chronic inflammation [<xref ref-type="bibr" rid="scirp.127948-ref18">18</xref>] . The thickness of the peri-implant epithelium was 52% of that in periodontitis. Based on the results, the inner implant epithelium appears to show weaker hyperplastic changes during the repair process than the inner epithelium around enamel.</p><p>This conjecture was consistent with the results of Ki-67 staining in the present study. Ki-67 is a cell-cycle-associated antigen present in all non-G0 phases of the cell cycle, and the commercially available MIB-1 clone has been applied widely in the practice of surgical pathology as a proliferative marker or prognostic factor [<xref ref-type="bibr" rid="scirp.127948-ref19">19</xref>] . In the present study, the proliferation rate of peri-implant (inner/outer) epithelium was significantly higher in periodontitis than in peri-implantitis. The JE with rapid turnover [<xref ref-type="bibr" rid="scirp.127948-ref17">17</xref>] originates from the enamel organ and constructs the inner marginal epithelium along with sulcular epithelium, which is derived from the oral epithelium [<xref ref-type="bibr" rid="scirp.127948-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref21">21</xref>] . On the other hand, the inner implant epithelium, which originates from the oral mucosa, has a lower capacity for a proliferative and regenerative mechanism than does the normal inner marginal epithelium [<xref ref-type="bibr" rid="scirp.127948-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref18">18</xref>] .</p><p>On the other hand, ultrastructural and immunocytochemical studies showed inferior adhesion and endocytic capacity of the peri-implant epithelium compared to normal JE [<xref ref-type="bibr" rid="scirp.127948-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref22">22</xref>] . Periodontitis is a complex inflammatory disease resulting from the interaction between the dental biofilm and host immune responses. The slow cell turnover and weak adhesion to the implant interface [<xref ref-type="bibr" rid="scirp.127948-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref22">22</xref>] are thought to be due to the fact that peri-implant epithelium has less of a protective function than normal peri-marginal epithelium [<xref ref-type="bibr" rid="scirp.127948-ref18">18</xref>] .</p><p>Concerning the innate immune response, HBDs, which are epithelial-derived antimicrobial peptides, may play a key role in susceptibility to periodontitis [<xref ref-type="bibr" rid="scirp.127948-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref12">12</xref>] . Of the HBDs, oral mucosal epithelium mainly produces HBD-1 to HBD-3 [<xref ref-type="bibr" rid="scirp.127948-ref8">8</xref>] . The antibacterial properties of HBD-3 were broader and stronger than those of HBD-1 and HBD-2 [<xref ref-type="bibr" rid="scirp.127948-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref24">24</xref>] . HBD-3 is synthesized by keratinocytes, monocytes, and CD4+ T cells and has a broad spectrum of potent antimicrobial activity against Gram-positive and Gram-negative bacteria [<xref ref-type="bibr" rid="scirp.127948-ref25">25</xref>] , in particular. It regulates wound healing, periodontitis, and carcinogenesis [<xref ref-type="bibr" rid="scirp.127948-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref27">27</xref>] . In the outer marginal epithelium of the present study, HBD-3 was detected predominantly in the basal layer and extended to the spinous layer in periodontitis, which was similar to a previous study [<xref ref-type="bibr" rid="scirp.127948-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref28">28</xref>] . Concerning the inner marginal epithelium, weak, strong, and slight HBD-3 positivity was mainly seen in the basal layer in control, periodontitis, and peri-implantitis, respectively, in the present study. These results for control and periodontitis are consistent with previous reports that showed that, when stimulated by external factors, the expression of HBD-3 in epithelial tissues was markedly increased, thus exerting its innate immune defense function [<xref ref-type="bibr" rid="scirp.127948-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref10">10</xref>] . Specifically, for each epithelial type, periodontitis showed significantly higher values than peri-implantitis in the present study. The results were consistent with Shimono et al.’s findings, which supported the notion that β-defensin in healthy inner marginal epithelium is a consequence of the inflammatory response [<xref ref-type="bibr" rid="scirp.127948-ref18">18</xref>] .</p><p>On the other hand, the inner implant epithelium showed very weak expression of HBD-3 even during inflammation in the present study. This result suggests the decreasing responsiveness of the inner implant epithelium to inflammation. In previous reports, HBD-3 was found to have important antibacterial activity, along with a possible role in inducing fibroblast proliferation, promoting periodontal regeneration [<xref ref-type="bibr" rid="scirp.127948-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.127948-ref12">12</xref>] . Furthermore, epithelial cells and fibroblasts are the predominant cells of periodontal tissues and serve as a first-line defense against periodontopathogens [<xref ref-type="bibr" rid="scirp.127948-ref29">29</xref>] . The little HBS-3 expression in the inner implant epithelium is significant in exploring the pathogenesis of peri-implantitis. Decreased production of HBD-3 in keratinocytes composing the inner implant epithelium may be one of the factors affecting tissue repair in peri-implantitis.</p><p>There are some limitations of the present study that must be recognized. There was considerable variation in the methods used for collecting, processing, and analyzing the inner epithelium samples. In addition, the synergistic action with other antimicrobial peptides was not examined. Furthermore, the number of samples in this study was not sufficient.</p></sec><sec id="s5"><title>5. Conclusions</title><p>The following could be concluded in the present study:</p><p>1) The inner epithelium around the implant exhibits weaker hyperplastic changes during the repair process compared to those in periodontitis.</p><p>2) The weak expression of HBD-3 in the inner implant epithelium is implicated in the pathogenesis of peri-implantitis.</p></sec><sec id="s6"><title>Acknowledgements</title><p>The authors would like to express their sincere gratitude to Mr. Masayuki Ukigaya for his valuable technical guidance in the preparation of pathological tissue specimens and immunohistochemical staining. This work was supported by JSPS KAKENHI Grant Number 22K12850.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Nakayama, Y., Taguchi, C., Nakayama, M., Suemitsu, M. and Kuyama, K. (2023) Histopathological and Immunohistochemical Study of Peri-Implant Epithelium. Open Journal of Stomatology, 13, 309-321. https://doi.org/10.4236/ojst.2023.139025</p></sec></body><back><ref-list><title>References</title><ref id="scirp.127948-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Rokaya, D., Srimaneepong, V., Wisitrasameewon, W., Humagain, M. and Thunyakitpisal, P. (2020) Peri-Implantitis Update: Risk Indicators, Diagnosis, and Treatment. European Journal of Dentistry, 14, 672-682. https://doi.org/10.1055/s-0040-1715779</mixed-citation></ref><ref id="scirp.127948-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Rinke, S., Nordlohne, M., Leha, A., Renvert, S., Schmalz, G. and Ziebolz, D. (2020) Risk Indicators for Mucositis and Peri-Implantitis: Results from a Practice-Based Cross-Sectional Study. Journal of Periodontal &amp; Implant Science, 50, 183-196. https://doi.org/10.5051/jpis.2020.50.3.183</mixed-citation></ref><ref id="scirp.127948-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Ikeda, H., Yamaza, T., Yoshinari, M., Ohsaki, Y., Ayukawa, Y., Kido, M.A., Inoue, T., Shimono, M., Koyano, K. and Tanaka, T. (2000) Ultrastructural and Immunoelectron Microscopic Studies of the Peri-Implant Epithelium-Implant (Ti-6Al-4V) Interface of Rat Maxilla. Journal of Periodontology, 71, 961-973. https://doi.org/10.1902/jop.2000.71.6.961</mixed-citation></ref><ref id="scirp.127948-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Inoue, T., Takeda, T., Lee, C.Y., Abiko, Y., Ayukawa, Y., Tanaka, T., Yoshinari, M. and Shimono, M. (1997) Immunolocalization of Proliferating Cell Nuclear Antigen in the Peri-Implant Epithelium. The Bulletin of Tokyo Dental College, 38, 187-193.</mixed-citation></ref><ref id="scirp.127948-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Chavrier, C.A. and Couble, M.L. (1999) Ultrastructural Immunohistochemical Study of Interstitial Collagenous Components of the Healthy Human Keratinized Mucosa Surrounding Implants. The International Journal of Oral &amp; Maxillofacial Implants, 14, 108-112.</mixed-citation></ref><ref id="scirp.127948-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Marchetti, C., Farina, A. and Cornaglia, A.I. (2002) Microscopic, Immunocytochemical, and Ultrastructural Properties of Peri-Implant Mucosa in Humans. Journal of Periodontology, 73, 555-563. https://doi.org/10.1902/jop.2002.73.5.555</mixed-citation></ref><ref id="scirp.127948-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Atsuta, I., Yamaza, T., Yoshinari, M., Goto, T., Kido, M.A., Kagiya, T., Mino, S., Shimono, M. and Tanaka, T. (2005) Ultrastructural Localization of Laminin-5 (γ2 Chain) in the Rat Peri-Implant Oral Mucosa around a Titanium-Dental Implant by Immuno-Electron Microscopy. Biomaterials, 26, 6280-6287. https://doi.org/10.1016/j.biomaterials.2005.03.046</mixed-citation></ref><ref id="scirp.127948-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Abiko, Y., Saitoh, M., Nishimura, M., Yamazaki, M., Sawamura, D. and Kaku, T. (2007) Role of β-Defensins in Oral Epithelial Health and Disease. Medical Molecular Morphology, 40, 179-184. https://doi.org/10.1007/s00795-007-0381-8</mixed-citation></ref><ref id="scirp.127948-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Zhu, M., Miao, B., Zhu, J., Wang, H. and Zhou, Z. (2017) Expression and Antimicrobial Character of Cells Transfected with Human β-Defensin-3 against Periodontitis-Associated microbiota in Vitro. Molecular Medicine Reports, 16, 2455-2460. https://doi.org/10.3892/mmr.2017.6913</mixed-citation></ref><ref id="scirp.127948-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Nishimura, M., Abiko, Y., Kusano, K., Yamazaki, M., Saitoh, M., Mizoguchi, I., Jinbu, Y., Noguchi, T. and Kaku, T. (2003) Localization of Human β-Defensin 3 mRNA in Normal Oral Epithelium, Leukoplakia, and Lichen Planus: An in Situ Hybridization Study. Medical Electron Microscopy, 36, 94-97. https://doi.org/10.1007/s00795-002-0206-8</mixed-citation></ref><ref id="scirp.127948-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Bissell, J., Joly, S., Johnson, G.K., Organ, C.C., Dawson, D., McCray Jr., P.B. and Guthmiller, J.M. (2004) Expression of β-Defensins in Gingival Health and in Periodontal Disease. Journal of Oral Pathology and Medicine, 33, 278-285. https://doi.org/10.1111/j.0904-2512.2004.00143.x</mixed-citation></ref><ref id="scirp.127948-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Wang, H., Watanabe, H., Ogita, M., Ichinose, S. and Izumi, Y. (2011) Effect of Human Beta-Defensin-3 on the Proliferation of Fibroblasts on Periodontally Involved Root Surfaces. Peptides, 32, 888-894.https://doi.org/10.1016/j.peptides.2011.02.002</mixed-citation></ref><ref id="scirp.127948-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Lindhe, J. and Meyle, J. (2008) Peri-Implant diseases: Consensus Report of the Sixth European Workshop on Periodontology. Journal of Clinical Periodontology, 35, 282-285. https://doi.org/10.1111/j.1600-051X.2008.01283.x</mixed-citation></ref><ref id="scirp.127948-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Sanz, M. and Chapple, I.L. (2012) Clinical Research on Peri-Implant Diseases: Consensus Report of Working Group 4. Journal of Clinical Periodontology, 39, 202-206. https://doi.org/10.1111/j.1600-051X.2011.01837.x</mixed-citation></ref><ref id="scirp.127948-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">(2013) Academy Report: Peri-Implant Mucositis and Peri-Implantitis: A Current Understanding of Their Diagnoses and Clinical Implications. Journal of Periodontology, 84, 436-443. https://doi.org/10.1902/jop.2013.134001</mixed-citation></ref><ref id="scirp.127948-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Metindir, J., Dilek, G.B. and Pak, I. (2008) Staining Characterization by Immunohistochemistry of Tumor Cancer Antigen in Patients with Endometrial Cancer. European Journal of Gynaecological Oncology, 29, 489-492.</mixed-citation></ref><ref id="scirp.127948-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Nakamura, M. (2018) Histological and Immunological Characteristics of the Junctional Epithelium. Japanese Dental Science Review, 54, 59-65. https://doi.org/10.1016/j.jdsr.2017.11.004</mixed-citation></ref><ref id="scirp.127948-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Shimono, M., Ishikawa, T., Enokiya, Y., Muramatsu, T., Matsuzaka, K., Inoue, T., Abiko, Y., Yamaza, T., Kido, M.A. and Tanaka, T. and Hashimoto, S. (2003) Biological Characteristics of the Junctional Epithelium. Journal of Electron Microscopy, 52, 627-639. https://doi.org/10.1093/jmicro/52.6.627</mixed-citation></ref><ref id="scirp.127948-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Hsu, C.-Y., Yang, C.-F., Liao, L.-R., Ho, H.-L. and Ho, D.M.-T. (2013) Tonsil Surface Epithelium Is Ideal for Monitoring Ki-67 Immunohistochemical Staining. Histopathology, 63, 810-816. https://doi.org/10.1111/his.12228</mixed-citation></ref><ref id="scirp.127948-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Nanci, A. and Bosshardt, D.D. (2006) Structure of Periodontal Tissues in Health and Disease. Periodontology 2000, 40, 11-28. https://doi.org/10.1111/j.1600-0757.2005.00141.x</mixed-citation></ref><ref id="scirp.127948-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Bampton, J.L.M., Shirlaw, P.J., Topley, S., Weller, P. and Wilton, J.M. (1991) Human Junctional Epithelium: Demonstration of a New Marker, Its Growth in Vitro and Characterization by Lectin Reactivity and Keratin Expression. Journal of Investigative Dermatology, 96, 708-717. https://doi.org/10.1111/1523-1747.ep12470948</mixed-citation></ref><ref id="scirp.127948-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Ikeda, H., Shiraiwa, M., Yamaza, T., Yoshinari, M., Kido, M.A., Ayukawa, Y., Inoue, T., Koyano, K. and Tanaka, T. (2002) Difference in Penetration of Horseradish Peroxidase Tracer as a Foreign Substance into the Peri-Implant or Junctional Epithelium of Rat Gingivae. Clinical Oral Implants Research, 13, 243-251. https://doi.org/10.1034/j.1600-0501.2002.130303.x</mixed-citation></ref><ref id="scirp.127948-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Joly, S., Organ, C.C., Johnson, G.K., McCray, P.B. and Guthmiller, J.M. (2005) Correlation between β-Defensin Expression and Induction Profiles in Gingival Keratinocytes. Molecular Immunology, 42, 1073-1084. https://doi.org/10.1016/j.molimm.2004.11.001</mixed-citation></ref><ref id="scirp.127948-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Harder, J., Bartels, J., Christophers, E. and Schroder, J.-M. (2001) Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide Antibiotic. Journal of Biological Chemistry, 276, 5707-5713. https://doi.org/10.1074/jbc.M008557200</mixed-citation></ref><ref id="scirp.127948-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Steinstraesser, L., Koehler, T., Jacobsen, F., Daigeler, A., Goertz, O., Langer, S., Kesting, M., Steinau, H., Eriksson, E. and Hirsch, T. (2008) Host Defense Peptides in Wound Healing. Molecular Medicine, 14, 528-537. https://doi.org/10.2119/2008-00002.Steinstraesser</mixed-citation></ref><ref id="scirp.127948-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Dale, B.A. (2002) Periodontal Epithelium: A Newly Recognized Role in Health and Disease. Periodontology 2000, 30, 70-78. https://doi.org/10.1034/j.1600-0757.2002.03007.x</mixed-citation></ref><ref id="scirp.127948-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Dommisch, H., Acil, Y., Dunsche, A., Winter, J. and Jepsen, S. (2005) Differential Gene Expression of Human β-Defensins (hBD-1, -2, -3) in Inflammatory Gingival Diseases. Oral Microbiology and Immunology, 20, 186-190. https://doi.org/10.1111/j.1399-302X.2005.00211.x</mixed-citation></ref><ref id="scirp.127948-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Lu, Q., Samaranayake, L.P., Darveau, R.P. and Jin, L. (2005) Expression of Human β-Defensin-3 in Gingival Epithelia. Journal of Periodontal Research, 40, 474-481. https://doi.org/10.1111/j.1600-0765.2005.00827.x</mixed-citation></ref><ref id="scirp.127948-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Bedran, T.B.L., Mayer, M.P.A., Spolidorio, D.P. and Grenier, D. (2014) Synergistic Anti-Inflammatory Activity of the Antimicrobial Peptides Human Beta-Defensin-3 (hBD-3) and Cathelicidin (LL-37) in a Three-Dimensional Co-Culture Model of Gingival Epithelial Cells and Fibroblasts. PLOS ONE, 9, e106766. https://doi.org/10.1371/journal.pone.0106766</mixed-citation></ref></ref-list></back></article>